Compare · ACAX vs COR
ACAX vs COR
Side-by-side comparison of Alset Capital Acquisition Corp. (ACAX) and Cencora Inc. (COR): market cap, price performance, sector, and recent activity on the wire.
Summary
- Both ACAX and COR operate in Other Pharmaceuticals (Health Care), so they compete in similar markets.
- COR carries a market cap of $7.54B.
- COR has more recent analyst coverage (24 ratings vs 0 for ACAX).
- Company
- Alset Capital Acquisition Corp.
- Cencora Inc.
- Price
- $3.85-63.71%
- $308.18-1.04%
- Market cap
- -
- $7.54B
- 1M return
- -
- -5.21%
- 1Y return
- -
- +7.11%
- Industry
- Other Pharmaceuticals
- Other Pharmaceuticals
- Exchange
- NASDAQ
- NYSE
- IPO
- 2022
- News (4w)
- 0
- 0
- Recent ratings
- 0
- 24
Alset Capital Acquisition Corp.
Alset Capital Acquisition Corp. focuses on effecting a merger, capital stock exchange, asset acquisition, stock purchase, reorganization, or similar business combination with one or more businesses. It intends to focus on identifying businesses in the real estate industry, including construction, homebuilding, real estate owners and operators, arrangers of financing, insurance, and other services for real estate, as well as businesses and technologies targeting the real estate space. The company was incorporated in 2021 and is based in Bethesda, Maryland.
Cencora Inc.
CoreSite Realty Corporation (NYSE:COR) delivers secure, reliable, high-performance data center, cloud access and interconnection solutions to a growing customer ecosystem across eight key North American markets. More than 1,375 of the world's leading enterprises, network operators, cloud providers, and supporting service providers choose CoreSite to connect, protect and optimize their performance-sensitive data, applications and computing workloads. Our scalable, flexible solutions and 460+ dedicated employees consistently deliver unmatched data center options  all of which leads to a best-in-class customer experience and lasting relationships.
Latest ACAX
- SEC Form SC 13G filed by Alset Capital Acquisition Corp.
- SEC Form SC 13G/A filed by Alset Capital Acquisition Corp. (Amendment)
- SEC Form SC 13G/A filed by Alset Capital Acquisition Corp. (Amendment)
- SEC Form SC 13G/A filed by Alset Capital Acquisition Corp. (Amendment)
- SEC Form SC 13G/A filed by Alset Capital Acquisition Corp. (Amendment)
- SEC Form SC 13G/A filed by Alset Capital Acquisition Corp. (Amendment)
- SEC Form SC 13G/A filed by Alset Capital Acquisition Corp. (Amendment)
- SEC Form 8-K filed by Alset Capital Acquisition Corp.
- SEC Form SC 13D/A filed by Alset Capital Acquisition Corp. (Amendment)
- SEC Form SC 13G filed by Alset Capital Acquisition Corp.
Latest COR
- SEC Form 4 filed by Krikorian Lazarus
- Cencora Announces Date and Time for Second Quarter Fiscal 2026 Earnings Release
- Amendment: SEC Form SCHEDULE 13G/A filed by Cencora Inc.
- Cencora Inc. filed SEC Form 8-K: Regulation FD Disclosure, Financial Statements and Exhibits
- Cencora to Expand Retina Consultants of America Through Acquisition of EyeSouth Partners' Retina Business
- Cencora Inc. filed SEC Form 8-K: Regulation FD Disclosure, Financial Statements and Exhibits
- Cencora Announces Financial Leadership Transition
- Executive Vice President Battaglia Silvana converted options into 8,415 shares and covered exercise/tax liability with 3,673 shares, increasing direct ownership by 25% to 23,566 units (SEC Form 4)
- Executive Vice President Campbell Elizabeth S converted options into 12,623 shares and covered exercise/tax liability with 5,842 shares, increasing direct ownership by 28% to 30,706 units (SEC Form 4)
- Chief Financial Officer Cleary James F covered exercise/tax liability with 5,409 shares and converted options into 12,623 shares, increasing direct ownership by 5% to 160,357 units (SEC Form 4)